← Back to Search

Public Messaging for Suicide Prevention in Veterans

N/A

Recruiting

Led By Elizabeth Karras Pilato, PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

>18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 1-month and 2-month follow up

Awards & highlights

Study Summary

This trial will test the use of public messaging to increase treatment seeking among Veterans at risk for suicide and resistant to seek mental health care following separation from military service.

Who is the study for?

This trial is for U.S. Veterans over 18 who've left the military in the last year, are experiencing suicidal thoughts, and have low intent to seek help but can consent to participate. They must own a smartphone and be willing to use a study app. Those currently or recently in mental health treatment or institutionalized cannot join.Check my eligibility

What is being tested?

The study aims to develop and test public messaging strategies designed to encourage Veterans at risk of suicide and resistant to seeking mental health care after leaving the military service, comparing message effectiveness with a wait list control group.See study design

What are the potential side effects?

Since this trial involves messaging strategies rather than medical interventions, traditional physical side effects are not expected; however, emotional distress due to sensitive content may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 1-month and 2-month follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 1-month and 2-month follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-month and 2-month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

change in treatment initiation from baseline to 1- and 2-month follow-up

Secondary outcome measures

Therapeutic procedure

change in intentions to seek treatment from baseline to 1- and 2-month follow-up

change in perceived treatment barriers from baseline to 1- and 2-month follow-up

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Message ExposureExperimental Treatment1 Intervention

Participants exposed to 4 study videos over a one-month period and complete telephone-based assessments at baseline, 1- and 2-month follow up. Study videos are delivered by study's mobile app downloaded to participants' own Smartphone.

Group II: Wait List ControlPlacebo Group1 Intervention

While wait-listed, participants will receive one push notification each week thanking them for participation, informing them that they will receive messages in the near future or reminding them of the length of the study. Telephone-based assessments are completed at baseline, 1- and 2-month follow up. Push notifications are delivered by study's mobile app downloaded to participants' own Smartphone.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Messaging

2022

N/A

~79480

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,609 Previous Clinical Trials

3,306,032 Total Patients Enrolled

38 Trials studying Suicide

5,198 Patients Enrolled for Suicide

Elizabeth Karras Pilato, PhDPrincipal InvestigatorCanandaigua VA Medical Center, Canandaigua, NY

Elizabeth Karras-Pilato, PhDPrincipal InvestigatorVA Finger Lakes Healthcare System, Canandaigua, NY

Media Library

Messaging Clinical Trial Eligibility Overview. Trial Name: NCT04784663 — N/A

Suicide Clinical Trial 2023: Messaging Highlights & Side Effects. Trial Name: NCT04784663 — N/A

Messaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT04784663 — N/A

Suicide Research Study Groups: Wait List Control, Message Exposure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to participate in this research project?

"For this trial, 420 individuals aged 18-89 who have suicidal ideation are eligible to participate. In addition, they need to be a U.S Veteran that separated from military service in the past 12 months (any discharge type), possess low intent of seeking help, comprehend the goals of the study, consent verbally and own a smartphone with willingness to download/use an associated mobile app."

Answered by AI

Is this experiment open to individuals 45 years of age and older?

"As indicated by the prerequisites, anyone aged 18 to 89 can join this trial. For those under 18 or over 65, there are 76 and 148 studies respectively that may be more suitable."

Answered by AI

Is this clinical investigation currently recruiting volunteers?

"Data available on clinicaltrials.gov proclaims that this medical experiment is actively searching for participants to join the trial. It was unveiled on November 1st 2022 and recently amended on November 28th 2022."

Answered by AI

What is the current enrollment size for this medical study?

"That is correct. The medical experiment, which was first posted on November 1st 2022, is actively recruiting according to clinicaltrials.gov. A total of 420 individuals are needed from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Public Messaging to Increase Treatment Seeking for Veterans at Risk for Suicide

2022. "Public Messaging to Increase Treatment Seeking for Veterans at Risk for Suicide". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04784663.